Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation

Marlene A Lopes,1,2,* Bárbara Abrahim-Vieira,3,* Claudia Oliveira,4,5 Pedro Fonte,6,7 Alessandra M T Souza,3 Tammy Lira,3 Joana A D Sequeira,1,2 Carlos R Rodrigues,3 Lúcio M Cabral,3 Bruno Sarmento,6–8 Raquel Seiça,9 Francisco Veiga,1,2 António J...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lopes MA, Abrahim-Vieira B, Oliveira C, Fonte P, Souza AMT, Lira T, Sequeira JAD, Rodrigues CR, Cabral LM, Sarmento B, Seiça R, Veiga F, Ribeiro AJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/785660afd90f40118ade6b51b2e3532f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:785660afd90f40118ade6b51b2e3532f
record_format dspace
spelling oai:doaj.org-article:785660afd90f40118ade6b51b2e3532f2021-12-02T00:46:38ZProbing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation1178-2013https://doaj.org/article/785660afd90f40118ade6b51b2e3532f2015-09-01T00:00:00Zhttps://www.dovepress.com/probing-insulin-bioactivity-in-oral-nanoparticles-produced-by-ultrason-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Marlene A Lopes,1,2,* Bárbara Abrahim-Vieira,3,* Claudia Oliveira,4,5 Pedro Fonte,6,7 Alessandra M T Souza,3 Tammy Lira,3 Joana A D Sequeira,1,2 Carlos R Rodrigues,3 Lúcio M Cabral,3 Bruno Sarmento,6–8 Raquel Seiça,9 Francisco Veiga,1,2 António J Ribeiro1,4,5 1Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; 2CNC – Center for Neuroscience and Cell Biology, Coimbra, Portugal; 3Department of Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; 4I3S, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal; 5Group Genetics of Cognitive Dysfunction, IBMC – Instituto de Biologia Molecular e Celular, Porto, Portugal; 6REQUIMTE, Department of Chemical Sciences – Applied Chemistry Lab, Faculty of Pharmacy, University of Porto, Porto, Portugal; 7CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra, Portugal; 8INEB – Instituto de Engenharia Biomédica, University of Porto, Porto, Portugal; 9IBILI – Institute of Biomedical Research in Light and Image, Faculty of Medicine, University of Coimbra, Coimbra, Portugal *These authors contributed equally to this work Abstract: Alginate–dextran sulfate-based particles obtained by emulsification/internal gelation technology can be considered suitable carriers for oral insulin delivery. A rational study focused on the emulsification and particle recovery steps was developed in order to reduce particles to the nanosize range while keeping insulin bioactivity. There was a decrease in size when ultrasonication was used during emulsification, which was more pronounced when a cosurfactant was added. Ultrasonication add-on after particle recovery decreased aggregation and led to a narrower nanoscale particle-size distribution. Insulin encapsulation efficiency was 99.3%±0.5%, attributed to the strong pH-stabilizing electrostatic effect between insulin and nanoparticle matrix polymers. Interactions between these polymers and insulin were predicted using molecular modeling studies through quantum mechanics calculations that allowed for prediction of the interaction model. In vitro release studies indicated well-preserved integrity of nanoparticles in simulated gastric fluid. Circular dichroism spectroscopy proved conformational stability of insulin and Fourier transform infrared spectroscopy technique showed rearrangements of insulin structure during processing. Moreover, in vivo biological activity in diabetic rats revealed no statistical difference when compared to nonencapsulated insulin, demonstrating retention of insulin activity. Our results demonstrate that alginate–dextran sulfate-based nanoparticles efficiently stabilize the loaded protein structure, presenting good physical properties for oral delivery of insulin. Keywords: biopolymers, insulin secondary structure, microparticle, molecular modeling, nanoencapsulation processing, oral deliveryLopes MAAbrahim-Vieira BOliveira CFonte PSouza AMTLira TSequeira JADRodrigues CRCabral LMSarmento BSeiça RVeiga FRibeiro AJDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 5865-5880 (2015)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Lopes MA
Abrahim-Vieira B
Oliveira C
Fonte P
Souza AMT
Lira T
Sequeira JAD
Rodrigues CR
Cabral LM
Sarmento B
Seiça R
Veiga F
Ribeiro AJ
Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
description Marlene A Lopes,1,2,* Bárbara Abrahim-Vieira,3,* Claudia Oliveira,4,5 Pedro Fonte,6,7 Alessandra M T Souza,3 Tammy Lira,3 Joana A D Sequeira,1,2 Carlos R Rodrigues,3 Lúcio M Cabral,3 Bruno Sarmento,6–8 Raquel Seiça,9 Francisco Veiga,1,2 António J Ribeiro1,4,5 1Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; 2CNC – Center for Neuroscience and Cell Biology, Coimbra, Portugal; 3Department of Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; 4I3S, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal; 5Group Genetics of Cognitive Dysfunction, IBMC – Instituto de Biologia Molecular e Celular, Porto, Portugal; 6REQUIMTE, Department of Chemical Sciences – Applied Chemistry Lab, Faculty of Pharmacy, University of Porto, Porto, Portugal; 7CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra, Portugal; 8INEB – Instituto de Engenharia Biomédica, University of Porto, Porto, Portugal; 9IBILI – Institute of Biomedical Research in Light and Image, Faculty of Medicine, University of Coimbra, Coimbra, Portugal *These authors contributed equally to this work Abstract: Alginate–dextran sulfate-based particles obtained by emulsification/internal gelation technology can be considered suitable carriers for oral insulin delivery. A rational study focused on the emulsification and particle recovery steps was developed in order to reduce particles to the nanosize range while keeping insulin bioactivity. There was a decrease in size when ultrasonication was used during emulsification, which was more pronounced when a cosurfactant was added. Ultrasonication add-on after particle recovery decreased aggregation and led to a narrower nanoscale particle-size distribution. Insulin encapsulation efficiency was 99.3%±0.5%, attributed to the strong pH-stabilizing electrostatic effect between insulin and nanoparticle matrix polymers. Interactions between these polymers and insulin were predicted using molecular modeling studies through quantum mechanics calculations that allowed for prediction of the interaction model. In vitro release studies indicated well-preserved integrity of nanoparticles in simulated gastric fluid. Circular dichroism spectroscopy proved conformational stability of insulin and Fourier transform infrared spectroscopy technique showed rearrangements of insulin structure during processing. Moreover, in vivo biological activity in diabetic rats revealed no statistical difference when compared to nonencapsulated insulin, demonstrating retention of insulin activity. Our results demonstrate that alginate–dextran sulfate-based nanoparticles efficiently stabilize the loaded protein structure, presenting good physical properties for oral delivery of insulin. Keywords: biopolymers, insulin secondary structure, microparticle, molecular modeling, nanoencapsulation processing, oral delivery
format article
author Lopes MA
Abrahim-Vieira B
Oliveira C
Fonte P
Souza AMT
Lira T
Sequeira JAD
Rodrigues CR
Cabral LM
Sarmento B
Seiça R
Veiga F
Ribeiro AJ
author_facet Lopes MA
Abrahim-Vieira B
Oliveira C
Fonte P
Souza AMT
Lira T
Sequeira JAD
Rodrigues CR
Cabral LM
Sarmento B
Seiça R
Veiga F
Ribeiro AJ
author_sort Lopes MA
title Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
title_short Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
title_full Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
title_fullStr Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
title_full_unstemmed Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
title_sort probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/785660afd90f40118ade6b51b2e3532f
work_keys_str_mv AT lopesma probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT abrahimvieirab probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT oliveirac probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT fontep probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT souzaamt probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT lirat probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT sequeirajad probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT rodriguescr probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT cabrallm probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT sarmentob probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT seicar probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT veigaf probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
AT ribeiroaj probinginsulinbioactivityinoralnanoparticlesproducedbyultrasonicationassistedemulsificationinternalgelation
_version_ 1718403505530601472